Chronic Obstructive Pulmonary Disease

BROVANA® (arformoterol tartrate)

BROVANA Inhalation Solution is a long-acting beta2-adrenergic agonist ( beta2-agonist) indicated for the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema

ARCAPTA® NEOHALER® (indacaterol inhalation powder)

ARCAPTA NEOHALER is a long-acting beta2-adrenergic agonist indicated for: The long term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

UTIBRON ® NEOHALER ® (indacaterol and glycopyrrolate)

UTIBRON NEOHALER is a combination of indacaterol, a long-acting beta2­ adrenergic agonist (LABA), and glycopyrrolate, an anticholinergic, indicated for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).